SC759596falsethe wholesale of pharmaceutical goods.2024-01-012024-12-31http://www.companieshouse.gov.uk/2023-12-31http://www.companieshouse.gov.uk/pt:ShareCapital2023-12-31http://www.companieshouse.gov.uk/cd:Director12024-01-012024-12-31http://www.companieshouse.gov.uk/pt:ShareCapital2024-12-31http://www.companieshouse.gov.uk/cd:Director22024-01-012024-12-31http://www.companieshouse.gov.uk/pt:DevelopmentCostsCapitalisedDevelopmentExpenditure2023-12-31http://www.companieshouse.gov.uk/cd:OrdinaryShareClass12024-01-012024-12-31http://www.companieshouse.gov.uk/pt:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-12-31http://www.companieshouse.gov.uk/cd:RegisteredOffice2024-01-012024-12-31http://www.companieshouse.gov.uk/cd:AuditExemptWithAccountantsReport2024-01-012024-12-31http://www.companieshouse.gov.uk/pt:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-01-012024-12-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2024-12-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2023-12-31http://www.companieshouse.gov.uk/2024-01-012024-12-31http://www.companieshouse.gov.uk/2023-12-31http://www.companieshouse.gov.uk/cd:FRS1022024-01-012024-12-31http://www.companieshouse.gov.uk/2024-12-31http://www.companieshouse.gov.uk/cd:FullAccounts2024-01-012024-12-31http://www.companieshouse.gov.uk/cd:PrivateLimitedCompanyLtd2024-01-012024-12-31iso4217:GBPxbrli:sharesxbrli:pure
Registered number: SC759596

Leith Healthcare Limited

UNAUDITED ACCOUNTS
FOR THE YEAR ENDED 31/12/2024

Prepared By:
NWE Accounting Services Ltd.
Bedford Ilab
Stannard Way
Bedford
MK44 3RZ

Leith Healthcare Limited

ACCOUNTS
FOR THE YEAR ENDED 31/12/2024
DIRECTORS
Richard Baderin
Richard Paul Grethe
REGISTERED OFFICE
Sugar Bond Anderson Place
Leith
Edinburgh
EH6 5NP
COMPANY DETAILS
Private company limited by shares registered in SC - Scotland, registered number SC759596
ACCOUNTANTS
NWE Accounting Services Ltd.
Bedford Ilab
Stannard Way
Bedford
MK44 3RZ

Leith Healthcare Limited

ACCOUNTS
FOR THEYEARENDED31/12/2024
CONTENTS
Page
Directors' Report-
Accountants' Report-
Statement Of Comprehensive Income-
Balance Sheet3
Notes To The Accounts4
The following do not form part of the statutory financial statements:
Trading And Profit And Loss Account-
Profit And Loss Account Summaries-

Leith Healthcare Limited

BALANCE SHEET AT 31/12/2024
20242023
Notes££
FIXED ASSETS
Intangible assets3250,000250,000
CURRENT ASSETS
Stock22,14025,223
Debtors515,0556,825
Cash at bank and in hand38,9503,349
76,14535,397
CREDITORS: Amounts falling due within one year6485,991431,156
NET CURRENT LIABILITIES(409,846)(395,759)
TOTAL ASSETS LESS CURRENT LIABILITIES(159,846)(145,759)
CAPITAL AND RESERVES
Called up share capital711
Profit and loss account(159,847)(145,760)
SHAREHOLDERS' FUNDS(159,846)(145,759)
For the year ending 31/12/2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors have decided not to deliver to the registrar a copy of the company's profit and loss account.
Approved by the board on 06/05/2025 and signed on their behalf by
.............................
Richard Baderin
Director

Leith Healthcare Limited

NOTES TO THE ACCOUNTS
FOR THE YEAR ENDED 31/12/2024
1. ACCOUNTING POLICIES
1a. Basis Of Accounting
The accounts have been prepared under the historical cost convention.
The accounts have been prepared in accordance with FRS102 section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006 .
1b. Intangible Assets
Licensing expenditure is normally written off in the year of expenditure, however expenditure incurred on specific projects is capitalised when recoverability can be foreseen with reasonable certainty and is amortised in relation to sales from such projects.
1c. Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell (net realisable value). Costs, which comprise direct production costs, are based on the method most appropriate to the type of inventory class, but usually on a first-in-first-out basis. Overheads are charged to profit or loss as incurred. Net realisable value is based on the estimated selling price less any estimated completion or selling costs.
When stocks are sold, the carrying amount of those stocks is recognised as an expense in the period in which the related revenue is recognised. The amount of any write-down of stocks to net realisable value and all losses of stocks are recognised as an expense in the period in which the write-down or loss occurs. The amount of any reversal of any write-down of stocks is recognised as a reduction in the amount of stocks recognised as an expense in the period in which the reversal occurs.
2. EMPLOYEES
20242023
No.No.
Average number of employees--

Leith Healthcare Limited

3. INTANGIBLE FIXED ASSETS
Development
CostsTotal
££
Cost
At 01/01/2024250,000250,000
At 31/12/2024250,000250,000
Depreciation
At 31/12/2024--
Net Book Amounts
At 31/12/2024250,000250,000
At 31/12/2023250,000250,000
4. STOCK 20242023
££
Stock comprises:
Stock22,14025,223
22,14025,223
5. DEBTORS 20242023
££
Amounts falling due within one year
Trade debtors2,4001,365
VAT8,715-
Other debtors-5,460
Prepayments3,940-
15,0556,825
6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
20242023
££
Directors current account30,000-
Trade creditors28,407-
Accruals600-
Amounts due to group companies426,984431,156
485,991431,156

Leith Healthcare Limited

7. SHARE CAPITAL 20242023
££
Allotted, issued and fully paid:
1 of £1 each11
11